Am. J. Respir. Cell Mol. Biol.,
Volume 19, Number 3, September, 1998 400-407
-Adrenoceptor-mediated Inhibition of IFN- , IL-3, and GM-CSF mRNA
Accumulation in Activated Human T Lymphocytes Is Solely Mediated by
the 2-Adrenoceptor Subtype
Peter
Borger,
Yke
Hoekstra,
Mariet T.
Esselink,
Dirkje S.
Postma,
Johan
Zaagsma,
Edo
Vellenga,
and
Henk F.
Kauffman
Divisions of Allergology, Pulmonology, Molecular Pharmacology, and Hematology, Department of Internal Medicine and
University Centre for Pharmacy, University of Groningen, Groningen, The Netherlands
Cytokine gene expression in T lymphocytes is a strictly regulated process, involving both stimulatory and
inhibitory signals. -Adrenoceptor ( AR) agonists are widely used in the treatment of asthma and are able
to induce an inhibitory signal on immunological responses after binding to their specific receptors. In this
study, the characterization of AR subtype(s) ( 1, 2, and 3) involved in the regulation of interleukin
(IL)-3, IL-4, granulocyte-macrophage colony-stimulating factor (GM-CSF), and interferon- (IFN- )
mRNA accumulation was studied by using various AR agonists and antagonists. Concanavalin A (Con
A)-induced IFN- , GM-CSF, and IL-3 mRNAs are dose-dependently inhibited by the nonselective AR
agonist isoproterenol and by the selective 2AR agonist fenoterol. IL-4 mRNA accumulation was not susceptible to AR stimulation. The observed inhibition on IFN- , GM-CSF, and IL-3 mRNA was blocked
by the selective 2AR antagonist ICI 118,551 (10 6 M) and by timolol (10 6 M), a nonselective antagonist. The selective 1AR antagonist atenolol (0.3 × 10 6 M) did not have any effect. Secretion of GM-CSF protein in the presence of increasing concentrations of isoproterenol followed a similar pattern as observed for GM-CSF mRNA. In addition, the AR-mediated inhibition of IFN- , GM-CSF, and IL-3
mRNA accumulation and GM-CSF protein secretion were related to the accumulation of intracellular cyclic adenosine monophosphate (cAMP) levels. Although 3AR mRNA was detectable in Con A-activated
T lymphocytes, we could not demonstrate a functional activity in the regulation of cytokine expression: the
3AR agonist BRL 37344 had no effect on the accumulation of the studied cytokine mRNAs, and did not significantly affect cellular cAMP levels. These data demonstrate that -agonist-induced inhibition of
IFN- , GM-CSF, and IL-3 mRNA accumulation is solely mediated by 2-adrenoceptors.
This article has been cited by other articles:

|
 |

|
 |
 
I. Ahmet, M. Krawczyk, W. Zhu, A. Y.-H. Woo, C. Morrell, S. Poosala, R.-p. Xiao, E. G. Lakatta, and M. I. Talan
Cardioprotective and Survival Benefits of Long-Term Combined Therapy with {beta}2 Adrenoreceptor (AR) Agonist and {beta}1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
491 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishii, T. Inomata, H. Niwano, H. Takehana, I. Takeuchi, H. Nakano, H. Shinagawa, T. Naruke, T. Koitabashi, J.-i. Nakahata, et al.
{beta}2-Adrenergic Agonists Suppress Rat Autoimmune Myocarditis: Potential Role of {beta}2-Adrenergic Stimulants as New Therapeutic Agents for Myocarditis
Circulation,
August 29, 2006;
114(9):
936 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. W. Kin and V. M. Sanders
It takes nerve to tell T and B cells what to do
J. Leukoc. Biol.,
June 1, 2006;
79(6):
1093 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Loza, S. Foster, S. P. Peters, and R. B. Penn
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
Blood,
March 1, 2006;
107(5):
2052 - 2060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chalothorn, H. Zhang, J. A. Clayton, S. A. Thomas, and J. E. Faber
Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia
Am J Physiol Heart Circ Physiol,
August 1, 2005;
289(2):
H947 - H959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Peek, D. F. Richards, A. Faith, P. Lavender, T. H. Lee, C. J. Corrigan, and C. M. Hawrylowicz
Interleukin-10-Secreting "Regulatory" T Cells Induced by Glucocorticoids and {beta}2-Agonists
Am. J. Respir. Cell Mol. Biol.,
July 1, 2005;
33(1):
105 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tse, B. A. Marroquin, D. R. Dorscheid, and S. R. White
{beta}-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2003;
285(2):
L393 - L404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Zoukos, T N Thomaides, D Kidd, M L Cuzner, and A Thompson
Expression of {beta}2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study
J. Neurol. Neurosurg. Psychiatry,
February 1, 2003;
74(2):
197 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P A Beckett and P H Howarth
Pharmacotherapy and airway remodelling in asthma?
Thorax,
February 1, 2003;
58(2):
163 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Kohm and V. M. Sanders
Norepinephrine and beta 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in Vivo
Pharmacol. Rev.,
December 1, 2001;
53(4):
487 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.H. Korn, A. Jerre, and R. Brattsand
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells
Eur. Respir. J.,
June 1, 2001;
17(6):
1070 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi
The Sympathetic Nerve---An Integrative Interface between Two Supersystems: The Brain and the Immune System
Pharmacol. Rev.,
December 1, 2000;
52(4):
595 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 American Thoracic Society.
|
|
|